[ad_1]
US President Donald Trump signed a decree Tuesday that gives the United States priority in receiving vaccines before exporting them, noting that the country may lack adequate doses after the first phase of vaccination. He explained that the decree states that “the United States government gives priority to vaccinating American citizens before shipping vaccines to other countries,” noting that the Pfizer / Bionic Alliance, which is expected to obtain a vaccine license in the next few days, has announced that the number of doses to be delivered in the United States will not exceed one hundred. Million.
In turn, the American company Moderna, whose vaccine could be licensed by the end of next week, promised one hundred million doses, and each contract provides options to receive additional doses, but the time limit to activate these terms may delay the delivery process for months. The United States has a population of 330 million and the government has confirmed that it can achieve its goal of ensuring vaccines for all of them by next April.
The two mentioned companies have factories in the United States and Europe, there are laws that theoretically allow the US government to obtain in advance the production of these factories, similar to the “Defense Production Act”. The decree Trump signed in front of reporters Tuesday at the White House after a meeting that discussed vaccines was not immediately released. “When necessary, we will go to the Defense Production Act,” Trump said. “We don’t think it’s necessary.”
There are two vaccines that have seen very positive results in clinical trials that could be licensed early next year to ensure that the United States gets sufficient quantities of a two-dose vaccine for AstraZeneca / Oxford. Washington has previously requested 500 million doses of it, and a single-dose vaccine for Johnson & Johnson is waiting for the United States to get one hundred million doses.
Source: French press agency
[ad_2]
